This Open Access volume provides in-depth analysis of the wide range of ethical issues
associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely
recognized to be one of the greatest threats to global public health in coming decades and it
has thus become a major topic of discussion among leading bioethicists and scholars from
related disciplines including economics epidemiology law and political theory. Topics
covered in this volume include responsible use of antimicrobials control of multi-resistant
hospital-acquired infections privacy and data collection antibiotic use in childhood and at
the end of life agricultural and veterinary sources of resistance resistant HIV tuberculosis
and malaria mandatory treatment and trade-offs between current and future generations. As the
first book focused on ethical issues associated with drug resistance it makes a timely
contribution to debates regarding practice and policy that are of crucial importance to global
public health in the 21st century.
